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Abstract
Objectives: Very few reports have described the Doppler-derived echocardiographic parameters for mechanical
pulmonary valve prosthesis (MPVP). This study aims to describe the normal Doppler hemodynamic profile of MPVP
using Doppler echocardiography.
Methods: The current prospective, single center observational study enrolled 108 patients who underwent
pulmonary valve replacement (PVR) surgery for the first time and had a normally functioning prosthesis post-
operation. The hemodynamic performance of MPVPs, considering flow dependent and flow independent
parameters, was evaluated at two follow-up points, at week one and week four post-operation. All assessments
were conducted by an experienced echocardiographer.
Results: The mean age (±SD) of the participants was 26.4 (±8.98). Tetralogy of Fallot (ToF) was the most common
underlying disease leading to PVR, with a prevalence of 88%. At first week post-operation, measurement of indices
reported the following values (±SD): peak pressure gradient (PPG): 18.51(±7.64) mm Hg; mean pressure gradient
(MPG): 10.88(±5.62) mm Hg; peak velocity (PV): 1.97(±0.43)m/s; doppler velocity index (DVI): 0.61(±18); pulmonary
velocity acceleration time (PVAT): 87.35(±15.16) ms; effective orifice area (EOA): 2.98(±1.02) cm2;and effective orifice
area to body surface area ratio (EOA/ BSA): 1.81(±0.62) cm2/m2. Comparing these measurements with those
obtained from the second follow-up (at week four post-op) failed to hold significant difference in all values except
for PVAT, which had increased from its primary value (p = 0.038). Also, right ventricular (RV) function showed significant
improvement throughout the follow up period.
Conclusion: The findings of this study help strengthen the previously scarce data pool and better establish the normal
values for Doppler hemodynamics in mechanical pulmonary prosthesis.
Keywords: Pulmonary mechanical prosthesis, Doppler-echocardiographic, Congenital heart diseases, Normal
hemodynamic profile
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Introduction
In recent years, mortality rates due to congenital cardiac
anomalies have significantly declined, leading to the pro-
longation of lifespan in affected individuals. Amongst such
anomalies, congenital defects of the right-side chambers
are commonly managed with Pulmonary Valve Replace-
ment (PVR). Individuals with Tetralogy of Fallot (ToF),
the most common and perhaps the most widely known
cause of cyanotic congenital cardiac diseases, now enjoy a
longer life as a result of recent advances [1]. However, no
gift comes without a price and future complications com-
monly haunt the patients later on in life, rendering re-
peated PVR operations a rational go-to solution in such
instances [2]. Re-operation, most commonly PVR, is per-
formed on close to 50% of individuals with TOF [3].
Two main type of valvular replacements are available:
Biologic and Mechanical. Although mechanical valves
are more durable, the use of these prosthesis is associ-
ated with an increased risk for thrombotic events requir-
ing lifelong anticoagulation therapy. This renders them
less favourable over the alternate option. However, it has
been suggested that the implication of proper anticoagu-
lation therapies can significantly reduce the risk of
thrombotic events [4].
The relatively less frequent application of mechanical
valves has resulted in a lack of knowledge regarding the
function of prosthetic valve replacements. Doppler echo-
cardiography is the method of choice for evaluation, in
both mechanical and biologic prosthesis, capable of
assessing a wide range of haemodynamic parameters [5].
Similar to native valves, normal Doppler echocardiog-
raphy profile can be measured for prosthetic transplants,
however the achieved profile may be heavily influenced
by a number of variables such as valve type, location,
size as well as patient-specific factors [6].
Normal haemodynamic values have been previously
determined for mitral and aortic valve prostheses [7].
However, the limited knowledge on mechanical pulmon-
ary valve prostheses (MPVP) has made the task of estab-
lishing normal haemodynamic values difficult in this
type of prosthesis. To address this problem, we aimed to
determine the haemodynamic profile of MPVPs in pa-
tients with desirable post-operation outcome, as estab-
lished by clinical and echocardiographic assessments. In
addition, a two-step evaluation was performed to negate
the short-term effects of open-heart surgery on the
haemodynamic profile of the prostheses, specifically on
right ventricular function.
Materials and method
This prospective cross-sectional study enrolled patients
who underwent pulmonary valve replacement surgery at
Shahid Rajaie Cardiovascular Medical and Research cen-
ter, between August 2016 and September 2019. Data
collection was performed at baseline (prior to surgery),
at one week, time of discharge, and four weeks after sur-
gery by trained staff with the use of a data collection
checklist. This study was approved by the Ethics Com-
mittee of the Iran University of Medical Sciences.
Study participants and implanted valve characteristics
Patients who underwent PVR operation for the first time
and those with normally functioning mechanical valve in
pulmonary position were eligible for this study. The ex-
clusion criteria were Suboptimal postoperative imaging
view and previous history of the Rastelli procedure or
other valve prostheses. All of the valves assessed in this
study were mechanical and obtained from three different
manufacturers: St. Jude (St. Jude Medical, USA), Carbo-
medics (SORIN group, Italy) and On-X (On-X life tech-
nologies, USA), with a diameter size varying between 21
mm to 31 mm.
Doppler echocardiographic procedure
Echocardiographic evaluation was performed in the left
lateral decubitus position. In order to minimize anticipa-
tion bias, a single specialist was assigned with the assess-
ment. In this study, we used a General Electric Vivid 7
phased array system (GE medical systems) equipped
with a multi-frequency 2.5–3.4MHz transducer. Apical,
parasternal, long and short axis views were assessed via
electrocardiogram signals of desirable quality and a
frame rate of 45–55 FPS.
Left ventricular Ejection Fraction was assessed optically
using the Simpson method. Right ventricular (RV) func-
tion was determined via visual assessment, tricuspid annu-
lus tissue systolic velocity and tricuspid annular plain
systolic excursion. The Likert scale was used to present
variables such as RV function, tricuspid regurgitation. Left
ventricular and RV size and function were graded accord-
ing to the recommendations of the American society of
echocardiography. MPVPs were considered functional
when the normal bi-leaflet motion of the prosthetic valve
was observed in parasternal short axis or parasternal RV
outflow view (see Fig. 1). Doppler evaluation of the pros-
theses assessed the flow velocity through the prosthesis
via pulse waves, continuous Doppler and color Doppler
imaging. In order to minimize angulation between Dop-
pler beams and flow direction, multiple windows were
used to obtain measurements and the highest overall vel-
ocity was recorded. Thereafter, Peak pressure gradient
(PPG), Mean pressure gradient (MPG) and the outer edge
of the peak velocity (PV) profile were drawn and applied
for the mean and peak gradients, which were automatic-
ally calculated by computer software using the simplified
Bernoulli equation, peak PVP velocity, Doppler velocity
index (DVI) that means ration of right ventricle outflow
tract (RVOT) velocity time integral (VTI),which measured
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by pulse wave Doppler, to PV VTI (by continuous Dop-
pler), pulmonary velocity acceleration time (PVAT) that
was obtained with time from the onset of flow to maximal
velocity (see Fig. 2). Tricuspid regurgitation was deter-
mined using the Bernoulli equation. After obtaining these
measurements, the EOA of the prostheses was determined
using the continuity equation: cross-sectional area of
RVOT*VTI of RVOT/VTI of prosthetic PV. The cross-
sectional area of RVOT was calculated based on the size
of the mechanical prosthetic.
Statistical analysis
Continuous variables were reported as means or median,
standard deviation (SD) or in ranges. Categorical and
nominal data were reported with absolute and relative
frequencies, and comparisons were carried out using
chi-square test and the Fisher’s exact test. Furthermore,
continues variables were compared using the paired t-
Test or, in instances which the data failed to fulfil the
parametric features, the Wilcoxon rank-sum test. Also,
one-way analysis of variance followed by Tukey Post hoc
test was used to compare parameters between valve
types. The Kruskal-Wallis H test was considered when
the data failed to fulfil parametric traits. The association
between continues variables was assessed using the Pear-
son Correlation test. The Spearman rank-correlation test
was used to compare nonparametric data or ordinal
measurements. To show the 95% confidence interval for
non-parametric data Bootstrap method at 1000 repeti-
tions was implemented. Two-tailed analysis was per-
formed in all instances and significance was determined
at P < 0.05. Statistical analyses were carried out using
SPSS software package v.20 for Windows (SPSS Inc.,
Chicago, Illinois).
Results
During the recruitment period a total of 141 patients
underwent PVR surgery. Of these cases 108 patients ful-
fill the eligibility criteria of this study and 33 patients
were excluded. However, of all these 33 patients, non
had history of previous PVR or any other cardiac sur-
gery. Although all eligible cases were present for their
first follow up, only 69 individuals visited the center for
their second follow up. Lack of access to the remaining
participants was the main cause of dropout (Fig. 3). Of
the 108 participants, 69(63.9%) were male. The mean
Fig. 1 Normal functioning of mechanical prosthesis in pulmonary position. a Normal opening of the prosthesis. b Normal closing of the prosthesis
Fig. 2 Doppler evaluation of a prosthetic pulmonary valve. a Tracing of pulmonary prosthesis doppler illustrating mean pressure gradient (MPG),
peak pressure gradient (PPG) and peak velocity (PV) of prosthesis. b Calculation of Doppler velocity index by dividing right outflow tract (RVOT)
VTI to pulmonary valve VTI c Obtaining acceleration time of mechanical prosthesis
Shojaeifard et al. Cardiovascular Ultrasound           (2020) 18:14 Page 3 of 9
age(±SD) of the participants was 26.4(±8.98). At the time
of echocardiographic evaluation, the global average heart
rate was 80.25(±12.13) and a sinus rhythm was observed
in all cases. In addition, all had participants exhibited
normal LV diastolic function. Ejection fraction was mea-
sured in both stages. The mean left ventricular ejection
fraction before and in first follow-up were 45.83% (±
6.21) and 45.41% (± 5.96), respectively. ToF (n = 95;88%)
was the most common underlying condition leading to
PVR. Regarding the manufacturer of the prostheses, St
Jude was implanted for 72 (66.7%) patients, which was
the most frequent prosthesis used in this study. The
baseline characteristics of the participants are summa-
rized in Table 1.
The data on doppler measurement of all MPVPs for
both stages was summarized in Table 2. At one-week
post-operation, right ventricular size was 4.11(±0.77).
Right ventricular function was also assessed at this
follow-up point: mild in one patient (0.9%), mild to
moderate in six patients (5.6%), moderate in 50 patients
(46.3%), moderate to severe in 39 patients (36%) and se-
vere in 12(11.1%) patients. The spearman correlation test
between the valve sizes and hemodynamic indices re-
vealed that valve size was positively correlated with
EOA/BSA (r: 0.306; P = 0.001). In addition, a marginal
correlation was observed between <PPG and valve size
(r = − 0.175, P = 0.071). Moreover, the correlation be-
tween the right ventricular systolic pressure and the
Fig. 3 Study population selection flowchart, PVR: pulmonary valve replacement
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PPG showed a significant association of these two pa-
rameters (r: 0.350; P = 0.001). The doppler measure-
ments of MPVPs based on the manufacturer and sized
at this stage are summarized in Table 3.
In the second follow-up the hemodynamic profile was
measured in 69 participants. Table 4 summarizes
the findings at this time-point according to the
manufacturer and sizes of the MPVPs. No patient
showed signs of valvular malfunction or other events re-
garding their recent valve replacement. At this stage the
size of right ventricle was significantly decreased to 3.81
(±0.71) (P = 0.006). Among the different measured
hemodynamic parameters, non had significant change
during the 3-week interval except PVAT which showed
a significant increase(P = 0.038). At this time, RV showed
significant reduction in size (P = 0.006) and improved
function (P = 0.001) since the previous follow up. More-
over, no significant differences were observed regarding
right ventricular systolic pressure and tricuspid regurgi-
tation gradient. The former altered from 35.38 (±14.27)
to 37.67 (±14.11), while the latter changed from 30.79 (±
13.50) to 32.31 (±13.81), (both P > 0.05).
Discussion
In this study, we have described the normal
hemodynamic profile for mechanical pulmonary valve
prosthesis in the postoperative period. To achieve this
goal, we performed early- and late-stage evaluation of
the prosthesis, since it had been previously established
in other prostheses that the results obtained from evalu-
ation may deviate significantly from those of the early
evaluation. Additionally, it was revealed that when ab-
normal function of prosthesis is suspected, previous
evaluation may aid by providing a basis for comparison
[8, 9]. To determine proper values of various valve-
related hemodynamic features and in order to distin-
guish the normal functioning prosthesis by this method,
the evaluation of an ample number of normally func-
tioning prostheses is required. In addition, previous at-
tempts on echocardiographic evaluation of prostheses in
other types of heart valves suggest that flow dependent
measurements can be of use only in the case of severe
prosthetic valve obstruction [10, 11]. Therefore, it is cru-
cial to measure Doppler-echocardiography parameters,
such as flow-independent parameters, EOA, EOA/BAS
and DVI, in order to detect and include instances of
mild obstruction [9].







Pulmonary insufficiency 105 (97.2%)
pulmonary stenosis 2 (1.9%)














pulmonary stenosis 8 (7.4%)
pulmonary insufficiency 3 (2.8%)
Atrioventricular septal defect 1 (0.9%)
Double outlet right ventricle 1 (0.9%)
Values are represented as mean(±SD) or n(%)
PVR pulmonary valve replacement, SJ St. Jude, ToF tetralogy of Fallot
Table 2 Normal parameters of mechanical prosthesis within follow-up points
Parameters First Follow-up (1 week) Second Follow-up (4 week) P-value
N = 108 N = 69
Peak Pressure Gradient 18.51 (17.14–19.88) 19.07 (16.49–22.01) 0.717
Mean Pressure Gradient 10.88 (9.85–11.97) 11.52 (9.89–13.41) 0. 526
Peak Velocity 1.97 (1.89–2.05) 2.02 (1.89–2.14) 0.629
Pulmonary velocity acceleration time 87.35 (84.49–89.97) 95.97 (89.82–102.37) 0.038
Doppler velocity index 0.67 (0.57–0.64) 0.56 (0.52–0.61) 0.229
Effective Orifice Area 2.98 (2.80–3.16) 2.79 (2.57–2.98) 0.397
Effective Orifice Area /Body surface area 1.81 (1.68–1.91) 1.72 (1.56–1.86) 0.559
Data represented as mean and 95%confidence interval
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PVR is the most frequent cardiac operation and reop-
eration performed on patients with congenital heart dis-
ease and the Bioprosthetic valves are currently the
choice for PVR in adults and children suffering from
pulmonary insufficiency [12–15]. Bioprosthetic valves
tend to deteriorate more rapidly in children, resulting in
inevitable repeat interventions [16–18]. Approximately
80% of bioprosthetic valves used in the pulmonary pos-
ition will require reoperation as soon as 10 years after
the initial surgery, regardless of age [17]. Due to their
higher durability, implanting mechanical prosthesis can
be a suitable alternative. The compulsory long-term use
of anticoagulants has resulted in the limited application
of mechanical valves. However recent attempts at PVP
assessment have reported promising long-term results
[19]. In contrast and from an echocardiographic ap-
proach as well as post-surgical surveillance, these pros-
theses have been less ventured upon.
Characterization and normal hemodynamic values of pul-
monary valve prostheses is limited to pulmonary homograft
valve conduits or xenograft pulmonary prosthesis [6]. Data
on normally functioning MPVPs have been reported in a
number of studies, albeit with limited cases [20, 21]. In a
study by Novaro et al., 51 pulmonary prosthesis were evalu-
ated out of which only 2 were mechanical, one SJ and one
Björk-Shiley and both 25mm in diameter [20]. In an ana-
lysis of 40 pulmonary prosthesis by Sadeghpour et al., only
13 were mechanical valves and three out of these mechan-
ical valves lacked proper function due to the presence of
massive obstructive thrombosis [21].
Patient-prostheses mismatch and the selection of pros-
thesis valve size are of vital importance and in our study,
we found a positive correlation between valve size with
EOA/BSA ratio. However, in contrast to the study by
Sadeghpour et al. [21], which showed a significant cor-
relation between MPG and valve sizes, a weak, margin-
ally positive correlation was observed in our results (P =
0.071). The reported coefficient in our study does not
represent a strong relation. This may arise from differ-
ences in types of prosthesis models and discrepancies
between the actual prosthesis size and that labeled by
the manufacturer. A similar positive correlation between
valve size with EOA/BSA ratio was observed in other
heart prosthesis [22].
The ideal time-points for postoperative transthoracic
echocardiography assessment of implanted valves are at
the time of discharge and 4–6 weeks after surgery [23].
This period is critical since most of the adverse effects of
surgery, as well as wound and graft healing are resolved
and concluded prior to the 6th week. In addition, im-
paired ventricular function will improve up to this time-
point [5]. Since we were unable of prolonging the study
until 6 weeks after surgery, follow ups were performed at
weeks 1 and 4 post-operation. Except for PVAT,
Table 3 Values of hemodynamic parameters in normal functioning mechanical prothesis based on valve type and sizes within first
follow-up








PVAT (ms) DVI EOA (cm2) EOA/BSA (cm2/m2)
St. Jude 2 21 20 (19–21) 12 (11–13) 2.15 (2.10–2.20) 97.5 (85–110) 0.50 (0.50–0.50) 1.73 (1.73–1.73) 1 (0.98–1.02)
18 23 20 (7–35) 11 (3.5–20) 2 (1.20–2.90) 87 (52–118) 0.60 (0.24–0.90) 2.49 (1–3.74) 1.64 (0.77–2.60)
43 25a 18.09(±7.45) 10.95(±5.85) 1.96(±0.43) 82.95(±10.83) 0.59(±0.20) 2.89(±0.98) 1.78(±0.64)
9 27 15 (6–30) 6 (3–18) 1.80 (1.20–2.70) 90 (72–116) 0.73 (0.55–0.84) 4.18 (3.15–4.81) 2.32 (1.82–3.16)
0 29 – – – – – – –
1 31 14 7 1.60 93 0.76 5.73 3.19
Carbomedics 0 21 – – – – – – –
2 23 18.5 (17–20) 12 (12–12) 2.00 (1.80–2.20) 77.5 (70–85) 0.40 (0.30–0.50) 1.66 (1.25–2.08) 0.98 (0.7–2.27)
14 25 19.50 (11–30) 11 (5–33) 2.05 (1.60–2.70) 88.5 (64–108) 0.67 (0.30–0.90) 3.26 (1.47–4.42) 1.84 (0.84–2.94)
2 27 19 (10–28) 10 (6–14) 1.90 (1.40–2.40) 77.5 (75–80) 0.71 (0.70–0.72) 4.06 (4.01–4.12) 2.26 (2.23–2.29)
1 29 14 7 1.70 76 0.4 2.64 1.89
0 31 – – – – – – –
On-X 0 21 – – – – – – –
3 23 20 (7–36) 12 (4–22) 2.20 (1.10–2.70) 112 (106–118) 0.80 (0.70–0.90) 3.32 (2.91–3.74) 2.37 (1.94–2.87)
10 25 16.50 (7–24) 10 (3–13) 1.80 (1.30–2.40) 100 (55–118) 0.55 (0.30–0.80) 2.70 (1.47–3.93) 1.46 (0.87–2.18)
1 27 23 13 2.20 113 0.7 4.01 1.91
2 29 20 (18–22) 11.50 (11–12) 2.10 (1.90–2.30) 102.5 (95–110) 0.55 (0.50–0.60) 3.63 (3.30–3.96) 2.02 (1.83–2.20)
– – – –
The parameters demons trated in median and range
PPG peak pressure gradient, MPG mean pressure gradient, PV pulmonary velocity, PVAT pulmonary velocity acceleration time, DVI doppler velocity index, EOA
effective orifice area, EOA/BSA effective orifice area division to body surface area
a Data represented as mean (±SD)
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measurements of hemodynamic indices did not exhibit
significant alteration between the two time points and
remained more or less constant. In aortic prosthetic
valves, the prolonged acceleration time is a hallmark of
stenosis and prosthesis malfunction [24] . In the pul-
monary position, however, delayed acceleration time is as-
sociated with improved outcomes in right heart function
[25]. In this position, the normal value of acceleration time
in adults and children is > 100ms > 120ms, respectively
[26]. The drastic number of lost cases may have contrib-
uted to the relatively constant values of indices obtained
at the follow ups. It is important to note that this absence
of change in measured values did not impact the severity
of post-surgical surveillance, since the risk of thrombo-
embolic events is high for mechanical valves, which is
highest in the first 3-month after surgery [22], therefore
we recommend the close observation of all patients who
will undergo mechanical prosthesis placement.
Limitations
Gradient is a flow-dependent parameter. Therefore, all
factors affecting valvular flow are also capable of influ-
encing the measured gradient. More importantly the
flow is dependent to the cardiac load. The loading con-
dition is one of such factors which may show variations
in different subjects following surgery. In turn, loading
condition itself is dependent on a number of other
variables, such as preload and afterload and alterations
in such parameters will also influence the measured
gradient. The size of the prosthesis may also impact the
measured gradient, although we have taken this param-
eter into consideration to better evaluate its impacts on
the overall outcome. One major limitation regarded to
doppler echocardiography is the alignment of doppler
echocardiography with the prothesis. To address this,
the utmost care was taken to maintain doppler echocar-
diography alignment with the prosthesis and reduce the
θ° to the minimum amount. However, in plenty of ToF
patients, the history of previous surgical events may
have altered the anatomical and geometric features of
the site of assessment, making it difficult, if not impos-
sible to maintain the aforementioned alignment and
hence obtaining the correct measure of gradients be-
come considerably difficult. An important limitation of
this study is was that only a select handful of valves, re-
garding both size and type, were available. This resulted
in fewer instances of very large and very small sizes be-
ing used during the operations. Furthermore, a dra-
matic drop was observed in the number of cases
participating for the second their second follow up,
possibly impacting the results. Moreover, to establish a
more sustainable profile of Doppler parameters, we rec-
ommend considering longer follow-up periods in fur-
ther studies.
Table 4 Values of hemodynamic parameters in normal functioning mechanical prothesis based on valve type and sizes within
second follow-up
Valve Subtypes Size (mm) Number PPG (mm Hg) MPG (mm Hg) PV (m/sec) PVAT (ms) DVI EOA (cm2) EOA/BSA (cm2/m2)
St. Jude 21 1 21 13 2.30 85 0.6 2.08 1.22
23 14 23.5 (10–45) 14 (6–30) 2.25 (1.50–3.20) 99.5 (65–140) 0.6 (0.3–0.9) 2.7 (1.25–3.74) 1.7 (0.73–2.91)
25 29 13 (7–73) 8 (2.5–45) 1.70 (1.10–4.10) 82 (35–185) 0.5 (0.3–0.9) 2.45 (1.47–4.42) 1.51 (0.86–3.25)
27 4 10.5 (6–16) 6 (4–9) 1.55 (1.10–1.90) 85.5 (75–110) 0.6 (0.4–0.7) 3.43 (2.29–4.01) 1.97 (1.27–2.21)
29 . . . . . . .
31 1 14 8 1.80 113 0.3 2.26 1.26
Carbomedics 21 . . . . . . .
23 1 25 17 2.40 101 0.6 2.49 1.52
25 7 20 (10–36) 16 (6–21) 2.20 (1.60–2.80) 121 (92–175) .70 (0.40–0.80) 3.43 (1.96–3.93) 1.94 (1.03–3.97)
27 1 19 11 2.10 98 0.6 3.43 1.91
29 1 14 7 1.80 100 0.6 3.96 2.83
31 . . . . . . .
On-X 21 . . . . . . .
23 2 28 (20–36) 17 (12–22) 2.60 (2.20–3.00) 107.5 (96–119) 0.75 (0.7–0.8) 3.11 (2.91–3.32) 2.15 (2.08–2.21)
25 7 19 (10–34) 12 (5–20) 2.10 (1.60–2.90) 85 (79–103) 0.5 (0.3–0.8) 2.94 (2.45–3.91) 1.72 (1.29–2.18)
27 1 6 3 1.20 65 0.3 1.72 0.82
29 . . . . . . .
31 . . . . . . .
The parameters demonstrated in median and range
PPG peak pressure gradient, MPG mean pressure gradient, PV pulmonary velocity, PVAT pulmonary velocity acceleration time, DVI doppler velocity index, EOA
effective orifice area, EOA/BSA effective orifice area division to body surface area Functioning Mechanical Prothesis Based on Valve Type and Sizes within
First Follow-up
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Conclusion
This descriptive analysis of patients who underwent mech-
anical pulmonary valve replacement surgery presents pre-
viously unavailable data on the subject of hemodynamic
indices of mechanical valves obtained in pulmonary pos-
ition. Although the finds of this study report
hemodynamic consistency throughout the study period,
the high risk of coagulation after surgery mandates the
recommendation of prophylactic anticoagulation therapy.
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